A new study from King's College London published in ecancer explores the associations between immune-suppressive and stimulating drugs and COVID-19.
The article analyses 89 existing studies on other coronavirus strains such as MERS and SARS, as well as the limited literature on COVID-19, to find out if certain pain medications, steroids, and other drugs used in people already suffering from diseases should be avoided if they catch COVID-19.
The authors found that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen for patients with COVID-19.
Read the open access article
Head of Publishing
+44(0) 117 942 0952
13 King Square Avenue, Bristol,
BS2 8HU, UK
HIFA profile: Katie Foxall is Head of Publishing at eCancer, Bristol, UK. katie AT ecancer.org